Trial Details
COMPLETEDBasic Information
| Clinical ID | c1186 |
|---|---|
| Identifier | NCT05452304 |
| Trial Title | AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Healthy Subjects|Crohns Disease |
| Interventions | BIOLOGICAL: AZD7798|BIOLOGICAL: Placebo |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Harrow |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2022-07-12 |
|---|---|
| Primary Completion Date | 2024-11-14 |
| Completion Date | 2024-11-27 |